Literature DB >> 10440279

Xeroderma pigmentosum in black South Africans.

W K Jacyk1.   

Abstract

BACKGROUND: Xeroderma pigmentosum occurs in all races. There is little information on its clinical picture, frequency, and types of malignant lesions in individuals of African negroid extraction.
METHODS: Fifteen black South African patients, aged from 10 months to 21 years, with xeroderma pigmentosum were prospectively studied. Detailed dermatologic, ophthalmologic, and neurologic examinations were carried out in all patients. Cutaneous, conjunctival, and lingual malignant lesions were histologically assessed. Complementation studies were not performed.
RESULTS: Twelve patients had cutaneous malignancies, predominantly squamous carcinomas, usually several at one time. Carcinomas of the tip of the tongue occurred in five patients and conjunctival carcinomas in four. Cutaneous and mucosal carcinomas developed at an earlier age than in the series from other parts of the world. Three patients had extensive skin involvement characteristic of xeroderma pigmentosum, but did not develop malignancies. They most likely belong to a complementation group(s) with higher rates of unscheduled deoxyribonucleic acid (DNA) synthesis.
CONCLUSIONS: Xeroderma pigmentosum in South African black people is characterized by the very early development of cutaneous, ocular, and tongue squamous cell carcinomas and usually has a rapid and devastating course.

Entities:  

Mesh:

Year:  1999        PMID: 10440279     DOI: 10.1046/j.1365-4362.1999.00724.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

1.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 2.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

3.  Squamous Cell Carcinoma Associated with Cosmetic Use of Bleaching Agents: About a Case in Ivory Coast.

Authors:  Koffi Kouamé Pacôme Gbandama; Almamy Diabaté; Kouamé Alexandre Kouassi; Yao Isidore Kouassi; Ange-Sylvain Allou; Mamadou Kaloga
Journal:  Case Rep Dermatol       Date:  2019-12-04

4.  Skin Cancer in People of Color: A Systematic Review.

Authors:  George A Zakhem; Akshay N Pulavarty; Jenna C Lester; Mary L Stevenson
Journal:  Am J Clin Dermatol       Date:  2021-12-13       Impact factor: 7.403

5.  Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.

Authors:  Brian P Brooks; Amy H Thompson; Rachel J Bishop; Janine A Clayton; Chi-Chao Chan; Ekaterini T Tsilou; Wadih M Zein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Nicholas T Iliff; Porcia Bradford; John J Digiovanna; Kenneth H Kraemer
Journal:  Ophthalmology       Date:  2013-04-16       Impact factor: 12.079

6.  Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis.

Authors:  Ruchi Mittal; Suryasnata Rath; Geeta Kashyap Vemuganti
Journal:  Saudi J Ophthalmol       Date:  2013-07

7.  Clinical and Mutational Spectrum of Xeroderma Pigmentosum in Egypt: Identification of Six Novel Mutations and Implications for Ancestral Origins.

Authors:  Eman Rabie; Khalda Amr; Suher Zada; Heba El-Sayed; Mohamad El Darouti; Ghada El-Kamah
Journal:  Genes (Basel)       Date:  2021-02-20       Impact factor: 4.096

8.  Elevated Levels of Soluble CTLA-4, PD-1, PD-L1, LAG-3 and TIM-3 and Systemic Inflammatory Stress as Potential Contributors to Immune Suppression and Generalized Tumorigenesis in a Cohort of South African Xeroderma Pigmentosum Patients.

Authors:  Mahlatse C M Kgokolo; Katherine Anderson; Shalate C Siwele; Helen C Steel; Luyanda L I Kwofie; Mike M Sathekge; Pieter W A Meyer; Bernardo L Rapoport; Ronald Anderson
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

9.  Acellular Dermal Matrix: Treating Periocular Melanoma in a Patient with Xeroderma Pigmentosa.

Authors:  Kamlen Pillay; Saleigh Adams; Laura Vandermaesen; Donald Anthony Hudson
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-08-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.